Abacavir (Ziagen)
Overview
- A Clinical Overview of Abacavir (ABC, Ziagen) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health - Prescribing Information for Abacavir (Ziagen) (PDF) (July 2008)
From GlaxoSmithKline - Drug Interactions: Abacavir (August 2004)
From Project Inform - HEPPigram: Management of the Abacavir Hypersensitivity Syndrome (AHS) (January 2002)
To read PDF, click here
In HEPP News, from Brown Medical School
News
- GlaxoSmithKline Announces New Program to Provide Financial Assistance for Eligible HIV Patients in the U.S. (November 11, 2008)
Program reduces out-of-pocket expense burden for eligible patients on GSK HIV medications.
From GlaxoSmithKline - Important Safety-Related Label Update for Ziagen (Abacavir Sulfate) (July 18, 2008)
From U.S. Food and Drug Administration - Ziagen's Heart Attack Link: How Long Has Glaxo Known? (May 12, 2008)
In The Independent - Guidelines Panel Responds to Abacavir Data (April 10, 2008)
From Project Inform - Early Communication About an Ongoing Safety Review of Ziagen (Abacavir) and Videx (Didanosine) (March 27, 2008)
From U.S. Food and Drug Administration - Ziagen Pills Packaged as Combivir (March 29, 2007)
From U.S. Food and Drug Administration - Two New Fixed-Dose Combinations Approved (August 2, 2004)
From U.S. Food and Drug Administration - Drug Development News: Fixed-Dose Combinations (May/June 2004)
The Food and Drug Administration's fast-track approval process for fixed-dose combinations is about to bear fruit.
In GMHC Treatment Issues, from Gay Men's Health Crisis
Clinical Management
Clinical Management
  |